139 related articles for article (PubMed ID: 3061035)
21. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
Thum J; Caspary L; Creutzig A; Alexander K
Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
[No Abstract] [Full Text] [Related]
22. [Clinical use of duplex ultrasound in peripheral arterial occlusive disease].
Seifert H; Jäger K
Vasa Suppl; 1989; 27():404-6. PubMed ID: 2696114
[No Abstract] [Full Text] [Related]
23. PGE1 treatment of severe skin ischemia in patients with peripheral arterial insufficiency--the effect on skin microcirculation.
Fagrell B; Lundberg G; Olsson A; Ostergren J
Vasa; 1986; 15(1):56-60. PubMed ID: 3962459
[No Abstract] [Full Text] [Related]
24. [A new oral prostaglandin E1 derivative (OP 1206) compared with intravenous PGE1: assessment of the effect on macro- and microcirculation].
Scheffler P; de la Hamette D; Pindur G; Gross J; Darbringhaus S
Vasa Suppl; 1991; 32():386-91. PubMed ID: 1771541
[No Abstract] [Full Text] [Related]
25. Are there predictors for the outcome of a PGE1 treatment in peripheral arterial disease with critical limb ischaemia?
Heidrich H; Schmidt T; Fahrig C
Vasa; 2005 May; 34(2):101-7. PubMed ID: 15968891
[TBL] [Abstract][Full Text] [Related]
26. [Administration of prostaglandin E1 in diabetics and non-diabetic patients with severe Fontaine stage IIb arterial occlusive disease].
Hinderer S; Brachmann R; Nedder KH; Bucher J; Beischer W
Vasa; 1991; 20(2):100-8. PubMed ID: 1877328
[TBL] [Abstract][Full Text] [Related]
27. [Transcutaneous pO2 and laser Doppler flux in increasing doses of intraarterial and intravenously administered prostaglandin E1].
Creutzig A; Caspary L; Ranke C; Kiessling D; Wilkens J; Frölich J; Alexander K
Vasa; 1987; 16(2):114-8. PubMed ID: 2955602
[No Abstract] [Full Text] [Related]
28. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
[No Abstract] [Full Text] [Related]
29. A new surgical approach to vasodilating therapy in peripheral occlusive vascular disease.
Horch R; Krönung G
Nihon Geka Hokan; 1988 Nov; 57(6):487-92. PubMed ID: 3268061
[No Abstract] [Full Text] [Related]
30. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
Balzer K; Rogatti W; Rüttgerodt K
Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
[TBL] [Abstract][Full Text] [Related]
31. [Effect of a transient intravenous infusion of isozsuprin on the peripheral blood flow in patients suffering from arterial occlusive disease of the limbs. A contribution to the effect of systemically-administered vasoactive drugs].
Ehringer H; Scheiber V
Wien Klin Wochenschr; 1972 Dec; 24(50):801-8. PubMed ID: 4642105
[No Abstract] [Full Text] [Related]
32. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
[TBL] [Abstract][Full Text] [Related]
33. [MR-Imaging of lower leg muscle perfusion].
Leppek R; Hoos O; Sattler A; Kohle S; Azzam S; Al Haffar I; Keil B; Ricken P; Klose KJ; Alfke H
Herz; 2004 Feb; 29(1):32-46. PubMed ID: 14968340
[TBL] [Abstract][Full Text] [Related]
34. [Results of intra-arterial administration of PGE1 prostaglandin].
Ciostek P; Kostewicz W; Górski G
Wiad Lek; 1994 Oct; 47(19-20):750-2. PubMed ID: 7483622
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of arterial ischemia of the extremities with intravenous infusions of nitroglycerin].
Shcherbiuk AN; Mikhaĭlov IP; Gorbunov SN
Sov Med; 1987; (5):112-4. PubMed ID: 3118482
[No Abstract] [Full Text] [Related]
36. [Laser Doppler flux motion in peripheral arterial occlusive disease].
Yanar A; Hoffmann U; Geiger M; Franzeck UK; Bollinger A
Vasa Suppl; 1989; 27():48-50. PubMed ID: 2696116
[No Abstract] [Full Text] [Related]
37. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
Heidrich H
Vasa Suppl; 1991; 33():346-7. PubMed ID: 1788752
[TBL] [Abstract][Full Text] [Related]
38. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
[No Abstract] [Full Text] [Related]
39. Study of thrombinic activation indexes, in patients with lower limb critic ischaemia, before and after prostaglandin E1 therapy.
Trifiletti A; Bartolone S; Scamardi R; Pizzoleo MA; Attinà A; Sottilotta G; Canobbio V; Soraci S; Barbera N
Minerva Cardioangiol; 1999 Mar; 47(3):55-8. PubMed ID: 10389444
[TBL] [Abstract][Full Text] [Related]
40. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
Rosak C; Hofmann U; König P; Nitsche GB
Vasa Suppl; 1991; 33():339-40. PubMed ID: 1788748
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
